8-K
CURRENT REPORT
- Company
- PharmaCyte Biotech, Inc.
- Filed
- July 21, 2022
- Period of Report
- July 21, 2022
- Accession Number
- 0001683168-22-005063
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →